Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT05912218 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

REducing Diabetic MacrovascUlar Complications DuE to Peripheral Arterial Disease- REDUCE-PAD

Study acronym: REDUCE-PAD
StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated November 21, 2024 (before its estimated September 1, 2025 completion). Its status may not reflect the trial's current state.

Record History

See every version on ClinicalTrials.gov ↗

  1. Start date changed from estimate of Jun 15, 2023 to Nov 2, 2023v2 Show 4 more changesShow less
    • Trial status: Not Yet Recruiting to Active, Not Recruiting
    • Study completion date: Sep 1, 2025 to Dec 1, 2025
    • Site details revised
    • Collaborators revised (3)
  2. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This is a Phase IIa, multi-centre study conducted at 3 sites in Singapore (SGH and NUHS, KTPH). 70 patients with diabetes mellitus (DM) and peripheral arterial disease (PAD) will be randomised in a ratio 1:1 to receive normal saline control or MEDI6570 400mg by monthly subcutaneous injection for 9 months.
Trial Details
NCT Number NCT05912218
Lead Sponsor National Heart Centre Singapore
Collaborators: Singapore General Hospital, Khoo Teck Puat Hospital, National University Health System, Singapore
Conditions
(from sponsor)		 Diabetes Mellitus, Type 2, Peripheral Arterial Disease
Related terms Diabetes Mellitus, Type 2, Peripheral Arterial Disease
Enrollment 70 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov